PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
118.09%
Revenue growth above 1.5x 6617.T's 11.88%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
134.81%
Gross profit growth above 1.5x 6617.T's 2.14%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
2047.84%
Positive EBIT growth while 6617.T is negative. John Neff might see a substantial edge in operational management.
810.34%
Positive operating income growth while 6617.T is negative. John Neff might view this as a competitive edge in operations.
929.47%
Positive net income growth while 6617.T is negative. John Neff might see a big relative performance advantage.
928.95%
Positive EPS growth while 6617.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
928.95%
Positive diluted EPS growth while 6617.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
37.71%
Positive 10Y revenue/share CAGR while 6617.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
56.91%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-35.67%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.14%
Below 50% of 6617.T's 129.51%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.56%
Positive 5Y CAGR while 6617.T is negative. John Neff might view this as a strong mid-term relative advantage.
-9.54%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
294.34%
10Y equity/share CAGR above 1.5x 6617.T's 5.73%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
56.00%
5Y equity/share CAGR above 1.5x 6617.T's 6.42%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
14.07%
3Y equity/share CAGR above 1.5x 6617.T's 1.93%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.41%
AR growth well above 6617.T's 23.49%. Michael Burry fears inflated revenue or higher default risk in the near future.
-31.45%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-5.08%
Negative asset growth while 6617.T invests at 1.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
11.77%
BV/share growth above 1.5x 6617.T's 1.18%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-15.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.64%
Our R&D shrinks while 6617.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-23.73%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.